Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin ...

MannKind’s fair value estimate has been trimmed from US$9.61 to US$7.50, a roughly 22% cut that sets a more conservative anchor for the stock. This reset lines up with a split analyst backdrop, where ...

Navigating the journey from research to real-world impact can be challenging. Luckily for Vanderbilt faculty, there's a network of Innovation ...